NDC 0641-6003-01 - Ativan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6003
- Requested NDC
- 0641-6003-01
- Package NDCs from labels
- 0641-6003-01, 0641-6003-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2026-09-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ATIVAN Injection (lorazepam injection, USP) | Hikma Pharmaceuticals USA Inc. | 2026-09-16 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6003-01 | Ativan | 1 mL in 1 VIAL | INJECTION | 1 | 12 | |
| 0641-6003-25 | Ativan | 25 in 1 CARTON | INJECTION | 25 | 12 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6003-01 | ML - Milliliter | 0641-6003 | 39234291-67c0-42e3-84e6-2343db75e106 | 1 | 2012-07-24 |
| 0641-6003-25 | ML - Milliliter | 0641-6003 | 36c00ab7-3d4c-4e2e-9097-56e1449101f1 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | ATIVAN (LORAZEPAM) INJECTION ATIVAN (LORAZEAPM) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | ATIVAN (LORAZEPAM) INJECTION ATIVAN (LORAZEAPM) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | ATIVAN (LORAZEPAM) INJECTION ATIVAN (LORAZEAPM) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | ATIVAN (LORAZEPAM) INJECTION ATIVAN (LORAZEAPM) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ATIVAN (LORAZEPAM) INJECTION ATIVAN (LORAZEAPM) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Civica, Inc. | 5140798d-8571-41fb-84a4-e182aac3f64c | 2026-11-09 | Boxed warning, Warnings, Adverse reactions | NDA018140 O26FZP769L |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Encon Safety Products, Inc. | b5a62567-c9f1-0492-e053-2a95a90ab247 | 2026-11-05 | Warnings | 6DC9Q167V3 |
| Visine Red Eye Total Comfort Multi-Symptom | TETRAHYDROZOLINE HYDROCHLORIDE, POLYETHYLENE GLYCOL 400, AND ZINC SULFATE, UNSPECIFIED FORM | Kenvue Brands LLC | 5747edef-7a87-41d7-9594-6c78508b9ba2 | 2026-11-04 | Warnings | B697894SGQ |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 1f79a5a1-0c40-45cf-8994-51f5ba3a5938 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 08a30230-fc95-9025-e063-6394a90ae21b | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PAI Holdings, LLC dba PAI Pharma | 711b60a3-028d-41d4-aa17-8f976e6df23e | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | SUN PHARMACEUTICAL INDUSTRIES INC | 0c1caa9c-9ef1-459c-86c3-adb939130a9f | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7afd9a59-3463-4eda-8cf3-ef90be05de3d | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7999b9c3-6185-4e4e-a4c3-d5d33d6c31d6 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| BACTERIOSTATIC | WATER | Elementco, S.A.P.I. de C.V. | 5e7465d8-dbe4-2f86-e063-6394a90a8dfb | 2026-10-23 | Warnings | LKG8494WBH |
| Visine Red Eye Hydrating Comfort | TETRAHYDROZOLINE HYDROCHLORIDE AND POLYETHYLENE GLYCOL 400 SOLUTION/ DROPS | Select Consumer Group | 5e153070-3668-f3c7-e063-6294a90a373b | 2026-10-17 | Warnings | B697894SGQ |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 0681c8db-ff09-4258-a5e0-76a26b0ea0af | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | B697894SGQ |
| Artifical Tears | GLYCERIN AND PROPYLENE GLYCOL | Wal-Mart Stores Inc | 99cfea82-afb8-4c5f-ac0c-492204a42c08 | 2026-10-02 | Warnings | 6DC9Q167V3 |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 1009c870-fd98-4e3b-81c8-4184036fb8c2 | 2026-09-30 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | ac1f88c2-2cf2-47de-a612-946cd4503090 | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Unit Dose Solutions, Inc. | 5c2cc4eb-cc84-f08c-e063-6394a90a605b | 2026-09-23 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Ativan | LORAZEPAM | Hikma Pharmaceuticals USA Inc. | 5fc0e987-61c9-40c4-b0d5-fcea07c8733e | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | NDA018140 0641-6003-25 0641-6001-01 0641-6003-01 0641-6000-01 0641-6000-10 0641-6001-25 0641-6002-10 0641-6002-01 0641-6001 0641-6002 0641-6000 0641-6003 00641600301 1665327 206820 1665188 1665326 238101 206819 238100 1665190 fb40dcce-9da3-49b4-9bde-e01a17abeae6 5fc0e987-61c9-40c4-b0d5-fcea07c8733e O26FZP769L |
| Lorazepam | LORAZEPAM | Clinical Solutions Wholesale, LLC | c0810422-b732-4c04-97d8-c1521c401ef4 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 86630bdd-13ad-4ab5-9e94-fcf2ea2113e1 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.